ad image

Preclinical Data

1 / 1
Mozart Therapeutics
Preclinical Data

Mozart Therapeutics Presents Compelling New Preclinical Data on MTX-201 at the 2025 Crohn's and Colitis Congress

Mozart Therapeutics

PR-02-25-NI-01Feb 07, 2025
Hemab Therapeutics
Annual Congress

Hemab Shares Phase 2 HMB-001 Data for Glanzmann Thrombasthenia & HMB-002 Preclinical Data for Von Willebrand at EAHAD 2025

Hemab Therapeutics

PR-01-25-NI-35Feb 07, 2025
Poseida Therapeutics
Preclinical Data

Poseida Therapeutics to Present New Preclinical Data Supporting Non-Viral Gene for the Treatment of Hereditary Angioedema

Poseida Therapeutics

PR-10-24-NI-63Oct 25, 2024
Skyhawk
Clinical Data

Skyhawk Therapeutics Presents Compelling Preclinical Data at the Molecular Targets and Cancer Therapeutics Symposium

Skyhawk

PR-10-24-NI-62Oct 25, 2024
Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data
Preclinical Data

Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data

Mark Mintz; Kristen M. Eisenhauer

Charles River Laboratories

PAO-05-23-CL-03May 05, 2023
CytoDyn Takes Steps towards a Brighter Future
Therapeutic Candidate

CytoDyn Takes Steps towards a Brighter Future

Cyrus Arman, Ph.D.

CytoDyn

PAO-02-23-CL-04Feb 06, 2023
Twist Bioscience
Antibodies

Twist Bioscience Announces Positive Preclinical Data for SARS-CoV-2 Antibodies

Twist Bioscience

PR-M11-20-022-1179Nov 24, 2020
Cabaletta Bio
CAR-T Immunotherapy

Cabaletta Bio Announces Presentation of Preclinical Data Showing Specific CAAR T Activity against Anti-MuSK Expressing B Cells

Cabaletta Bio

PR-M10-19-NI-024Oct 15, 2019
Preclinical Studies Bode Well for Diabetes Drug from Semma Therapeutics
Diabetes

Preclinical Studies Bode Well for Diabetes Drug from Semma Therapeutics

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M07-19-NI-009Jul 10, 2019
Sangamo Therapeutics
Cell and Gene Therapy

Sangamo Therapeutics Presents New Preclinical Data Demonstrating Significant Reduction In Tau Expression With Gene Regulation Technology

Sangamo Therapeutics

PR-M04-19-NI-012Apr 03, 2019
Alligator Bioscience: New Preclinical Data Demonstrate Strong Anti-tumor Effects for the 4-1BB Antibody ATOR-1017
Preclinical Data

Alligator Bioscience: New Preclinical Data Demonstrate Strong Anti-tumor Effects for the 4-1BB Antibody ATOR-1017

Nice Insight

PR-M03-19-NI-053Mar 20, 2019
Artemis Therapeutics
Preclinical Data

Artemis Therapeutics Announces Two Recent Publications Highlighting Artemisone's Activity Against Human Cytomegalovirus And Malaria

Artemis Therapeutics

PR-M06-18-NI-063Jun 20, 2018
Advaxis, Inc.
Preclinical Data

Recently Presented Preclinical Data Show Potential for ADXS-NEO as Anti-Cancer Immunotherapy Agent

Advaxis, Inc.

PR-M05-18-NI-056May 15, 2018
1 / 1